Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
期間:
書込みモード:
| 出来高 | 1,221,680 |
|
|||||
| ニュース | (2) |
| 名称 | 銘柄コード | 市場 | 種別 |
|---|---|---|---|
| SAB Biotherapeutics Inc | SABSW | NASDAQ | Equity Warrant |
| 前日比 | 前日比 % | 現在値 | 時刻
|
|
|---|---|---|---|---|
| 0.0105 | 100.00% | 0.021 | 04:40:22 |
| 始値 | 安値 | 高値 | 終値 | 前日終値 |
|---|---|---|---|---|
| 0.0105 | 0.0105 | 0.055 | 0.0105 |
| 取引数 | 出来高 | VWAP | Financial Volume | 平均音量 |
|---|---|---|---|---|
| 1,142 | 1,221,680 | 0.0347239 | 42,421 | - |
| 最終取引 | タイプ | 数量 | 価格 | 通貨 |
|---|---|---|---|---|
| 04:40:21 | 591 | 0.021 | USD |
企業情報 - SAB Biotherapeutics Inc
| 時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
|---|---|---|---|---|---|---|
| 1.61M | - | - | - | - |
| Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ニュース - SAB Biotherapeutics
| 日付 | 時間 | 情報元 | タイトル |
|---|---|---|---|
| 2026/7/07 | 21:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2026/7/07 | 21:00 | GlobeNewswire Inc. | Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of.. |
| 2026/6/19 | 05:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2026/5/29 | 21:00 | GlobeNewswire Inc. | SAB BIO to Present Data on SAB-142 at The American Diabetes.. |
| 2026/5/15 | 19:28 | Edgar (US Regulatory) | Form SCHEDULE 13G - Statement of Beneficial Ownership by.. |
| 2026/5/12 | 20:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2026/5/12 | 20:30 | GlobeNewswire Inc. | SAB BIO Reports Q1 2026 Financial Results and Recent.. |
| 2026/5/05 | 21:30 | GlobeNewswire Inc. | SAB BIO to Host First Quarter 2026 Financial Results.. |
| 2026/5/05 | 05:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2026/5/01 | 05:45 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 2026/4/22 | 21:13 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2026/4/22 | 20:00 | GlobeNewswire Inc. | SAB BIO Presents Additional Clinical and Mechanistic Data.. |
チャート - SAB Biotherapeutics
| 期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
|---|---|---|---|---|---|---|---|
| 1週 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5年 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
NASDAQ:SABSW -
What is the current SAB Biotherapeutics Inc share price?
The current share price of SAB Biotherapeutics Inc is US$ 0.021
What is the 1 year trading range for SAB Biotherapeutics Inc share price?
SAB Biotherapeutics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
